The French company Carmat will restart the implantations of its artificial heart in France, after having received the regulatory authorizations necessary to resume its clinical study in France,…
CARMAT (FR0010907956, ALCAR), the designer and developer of Aeson®, the world’s most advanced total artificial heart, designed to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, announced today that it has been granted the necessary regulatory approvals from the .
Legislative panel preps mental health bills for 2023 session nevadacurrent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nevadacurrent.com Daily Mail and Mail on Sunday newspapers.
22.12.2021 - Regulatory News: Pherecydes Pharma (FR0011651694 – ALPHE) (Paris:ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces that it has obtained ANSM (French . Seite 1
PhagoDAIR is a phase I/II clinical study with anti-Staphylococcus aureus phages in the treatment of osteoarticular infections of prostheses caused by this bacterium Patient enrollment should